Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HepG2 cell membrane proteins
- Molecular classification
- Other (mixture of multiple protein families including transporters, receptors, enzymes, glycoproteins, etc.), Transporter, Receptor, Enzyme, Structural protein
01
Overview
The category "HepG2 cell membrane proteins" refers collectively to all proteins present on the plasma membrane of HepG2 cells, a widely studied human hepatic tumor cell line[3][4]. These proteins include various transporters such as MDR1/P-glycoprotein, receptors like the insulin receptor and the asialoglycoprotein receptor, enzymes, adhesion molecules, and other structural proteins that mediate functions such as cell signaling, drug transport, cell adhesion, and metabolism[1][4][6]. The specific composition varies based on culture conditions, cell cycle phase, and experimental manipulation. As a group, this is not a well-defined therapeutic "target" but rather a collection of diverse proteins used for broad studies in cancer biology, drug transport, and liver-specific physiology.
- Other names
- HepG2 plasma membrane proteinsHepG2 surface proteins
02
Mechanism of action
Efflux transport (via MDR1/P-glycoprotein) Receptor-mediated signaling (e.g., insulin receptor, asialoglycoprotein receptor) Organic anion transport Variable, based on individual protein
03
Biological functions
Signal transductionCell adhesionCell proliferationCell cycle regulationApoptosisImmune responseCell migrationMetabolism
04
Disease associations
Cancer (hepatocellular carcinoma, hepatoblastoma)Infection (as relevant to hepatitis B virus research)Other (depends on the specific membrane protein studied)
05
Safety considerations
Non-specificity: HepG2 membrane proteins mixture is not a therapeutic target, hence drugs targeting the mixture would have off-target effects.Individual proteins may have safety concerns (e.g., MDR1 inhibitors risk increased toxicity from lack of efflux)Cancer-related membrane proteins may facilitate invasion and metastasis
06
Interacting drugs
Numerous drugs interact with HepG2 cell membrane proteins as part of drug metabolism, cytotoxicity, and transport studies, including:
4 more in the full profile.
07
Biomarkers
MDR1/P-glycoprotein expression (marker of multidrug resistance)Annexin A2 (marker in cancer progression and metastasis)Asialoglycoprotein receptor (marker of hepatocyte differentiation)Others, depending on specific protein
Beyond the preview
Go deeper on HepG2 cell membrane proteins.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HepG2 cell membrane proteins.